According to a study, the risk of blood clots in the veins was 33 times higher during the first week following contamination.
The infection at Covid-19 leaves traces in the body. A year following the contamination, some dangers still exist. According to a recent study, the risk of life-threatening blood clots remains for at least 49 weeks. This finding, reported by EurekAlertwas made by looking at data from the health records of 48 million adults not vaccinated once morest the virus.
According to this study (conducted by researchers from the Universities of Bristol, Cambridge and Edinburgh and Swansea University), the Covid-19 outbreak has led to 10,500 additional cases of heart attacks, strokes and strokes. other blood clot complications in England and Wales for the year 2020. This data was collected before the mass vaccination and multiplication of variants.
The risk of blood clots in the veins was 33 times higher in the first week following being diagnosed with Covid-19. This risk fell to eight times following four weeks. During this study, the researchers also analyzed the problems caused by blood clots in the veins (such as deep vein thrombosis and pulmonary embolism). In detail, a week following being diagnosed with Covid-19, patients were 21 times more likely to have a heart attack or stroke. A figure that fell to 3.9 times following four weeks.
VIDEO – Dr Christian Recchia: “When someone has a stroke in front of you, you only have a few minutes to save him”
Heart attacks and strokes
“We are reassured that the risk is falling quite quickly – particularly for heart attacks and strokes – but the finding that this risk remains high for some time highlights the longer-term effects of Covid-19 that we are only beginning to understand“, explains Jonathan Sterne, professor of medical statistics and epidemiology at the University of Bristol and co-director of this study.
Between 26 and 49 weeks following contamination, the higher risk of having a blood clot was 1.3 times in the arteries and 1.8 times in the veins. These findings were published in the journal Circulation.
VIDEO – Bivalent vaccines once morest Covid-19 are developing on the European market
